Altimmune ALT Payments Of Deferred Offering Costs
Payments Of Deferred Offering Costs at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept alt:PaymentsOfDeferredOfferingCosts.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's payments of deferred offering costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's payments of deferred offering costs?
- Altimmune (ALT) reported payments of deferred offering costs of $89K in Q1 2026.
- How has Altimmune's payments of deferred offering costs changed year-over-year?
- Altimmune's payments of deferred offering costs decreased by 28.8% year-over-year, from $125K to $89K.
- What does payments of deferred offering costs mean?
- This represents cash outflows associated with the preparation and execution of equity or debt offerings, such as legal, accounting, and underwriting fees. These costs are initially deferred and subsequently amortized or offset against the proceeds of the offering. Monitoring these payments helps investors understand the capital-raising efficiency and the friction costs associated with accessing public markets.